This effect decreases the rate of migration in breast cancer cell lines, assuming a cooperation of MAML1 with other pathways, in particular p53, which is able to down-regulate the EMT markers expression (Shariat Razavi et al., 2019). Here, MAML1 is linked to breast carcinoma.